FDA approves Erwinaze to treat a form of leukemia

Links shared publicly online about this topic.

0
total visits

FDA approves Erwinaze to treat a form of leukemia

The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.

View full resource at fda.gov

Tags: Allergies, E coli, Leukemia, Diet and Nutrition, Drug, FDA